Charlotte Johanna Cool

Dr. Charlotte Johanna Cool


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 June 2024 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
PDF file
CCCharlotte Johanna Cool
Charlotte Johanna Cool
AKAchmad Fitrah Khalid
Achmad Fitrah Khalid
NSNorman Sukmadi
Norman Sukmadi
MAMohammad Rizki Akbar
Mohammad Rizki Akbar
BSBudi Setiabudiawan
Budi Setiabudiawan
SRSri Endah Rahayuningsih
Sri Endah Rahayuningsih
Background: Atrial septal defects (ASD) are the most common type of adult congenital heart disease (ACHD) associated with a high risk developing of pulmonary arterial hypertension (PAH). ASD closure is not recommended in patients with PAH and Pulmonary Vascular Resistance (PVR) ≥ 5 Wood Unit (WU). Noninvasive methods have been proposed to measure PVR; however, their accuracy remains low. Right Ventricle (RV) - Pulmonary Artery (PA) coupling is defined as the ability of the RV to adapt to high-resistance conditions. Tricuspid Annular Plane Systolic Excursion (TAPSE)/estimated pulmonary artery systolic pressure (ePASP) calculation using echocardiography is a noninvasive technique that has been proposed as a surrogate equation to evaluate RV-PA coupling. Currently, no research has demonstrated a relationship between RV-PA coupling and PVR in patients with ASD. Methods: The study participants were consecutive eligible patients with ASD who underwent right heart catheterization (RHC) and echocardiography at Hasan Sadikin General Hospital, Bandung. Both the procedures were performed on the same day. RV-PA Coupling, defined as TAPSE/ePASP > 0.31, was assessed using echocardiography. The PVR was calculated during RHC using the indirect Fick method. Results: There were 58 patients with ASD underwent RHC and echocardiography. Among them, 18 had RV/PA Coupling and 40 had RV/PA Uncoupling. The PVR values were significantly different between the two groups (p = 0.000). Correlation test between TAPSE/ePASP with PVR showed moderate negative correlation (r= -0.502, p = 0.001). TAPSE/ePASP ≤ 0.34 is the cutoff point to predict PVR > 5 WU with sensitivity of 91.7% and specificity 63.6%. Conclusion: This study showed a moderate negative correlation between TAPSE/ePASP and PVR. TAPSE/ePASP ≤ 0.34 could predict PVR > 5 WU with good sensitivity.

1 March 2024 in International Journal of General Medicine
Verified
Journal Article
Open access
PDF file
HPHawani Sasmaya Prameswari
Hawani Sasmaya Prameswari
TDTriwedya Indra Dewi
Triwedya Indra Dewi
MHMelawati Hasan
Melawati Hasan
EMErwan Martanto
Erwan Martanto
AAAstri Astuti
Astri Astuti
CCCharlotte Johanna Cool
Charlotte Johanna Cool
Background: Due to the rarity of peripartum cardiomyopathy (PPCM) globally, baseline characteristic data for PPCM patients are still scarce. Therefore, this study aims to determine the baseline characteristics and 6-month outcomes of PPCM patients in Indonesia. Methods: From January 2014 to December 2021, all PPCM patients aged ≥ 18 years who were admitted to Dr. Hasan Sadikin General Hospital in Bandung, Indonesia, participated in this single-center, prospective cohort study. All patients were re-evaluated within 6 months of PPCM diagnosis. Results: A total of 138 patients with PPCM were admitted to Dr. Hasan Sadikin General Hospital in Bandung. The mean age of all patients was 30.4 ± 6.4 years old. Approximately 60% patients were multipara and had preeclampsia. All guideline-directed medical therapy for heart failure was received by most patients, excluding mineralocorticoid receptor antagonists (25.2%) and bromocriptine (14.1%). The neonatal mortality rate was 5.1%. Among those who survived, 61.2% had normal weight, 31.8% had low birth weight, and 7% had very low birth weight. At the 6-month follow-up, 6.7% of the patients died, 63.3% recovered, and 1.9% were rehospitalized. Conclusion: The present study found a high incidence of PPCM in Indonesia. Our patients frequently had preeclampsia, which contributed to the higher rate of miscarriage and low birth weight. Our liberal use of beta-blockers and ACEi/ARB may have contributed to the higher 6-month recovery rate than that in other countries.

5 March 2022 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
PDF file
CCCharlotte Johanna Cool
Charlotte Johanna Cool
FFFathy Fathini
Fathy Fathini
IAIbnu Adams
Ibnu Adams
ASAninka Saboe
Aninka Saboe
NKNuraini Yasmin Kusumawardhani
Nuraini Yasmin Kusumawardhani
AYAchmad Fauzi Yahya
Achmad Fauzi Yahya
Background: Left main coronary artery disease secondary to pulmonary artery compression related to Eisenmenger syndrome is an under-suspected condition that can cause fatal outcomes if left untreated. It presents with typical angina but is frequently mistaken for pulmonary hypertension (PH) symptoms. It is now recognized as one of the few important causes of angina in PH. Case presentation: A 37-year-old man with a history of unoperated atrial septal defect and Eisenmenger syndrome came to the outpatient department with a chief complaint of angina on exertion. Electrocardiogram showed regular sinus rhythm with right axis deviation, right ventricular hypertrophy, deep T-wave inversion in inferior and anterior leads suggestive of ischemia or strain, and incomplete right bundle branch block. Cardiac CT showed compression of the left main coronary artery due to a dilated main pulmonary artery. Therefore, this patient was diagnosed with Eisenmenger syndrome with left main compression due to dilated pulmonary artery. He was treated successfully with IVUS-guided stent implantation. The patient experienced marked improvement in regular activities, with no recurrence of angina symptoms. Angiography 3 months after the procedure revealed good patency of the stent, without significant stenosis. Conclusions: Left main coronary artery compression is a complication that should be suspected in patients with Eisenmenger syndrome presenting with angina symptoms. Non-invasive modalities are recommended for diagnostic evaluation, but the gold-standard technique remains coronary angiography. The best treatment is not well-established, with either myocardial revascularization or PH treatment, but a left main coronary artery stenting procedure is considered an ideal emergent treatment to provide a better quality of life for patients in this condition.

26 April 2025 in American Journal of Case Reports
Verified
Journal Article
Open access
CCCharlotte Johanna Cool
Charlotte Johanna Cool
IPIwan Cahyo Santosa Putra
Iwan Cahyo Santosa Putra
WKWilliam Kamarullah
William Kamarullah
NSNorman Sukmadi
Norman Sukmadi
MPMiftah Pramudyo
Miftah Pramudyo
PRPradana Pratomo Raharjo
Pradana Pratomo Raharjo
Infective endocarditis (IE) involving isolated vegetations in the pulmonary artery is an exceedingly rare clinical entity. The absence of standardized guidelines regarding management and timing of intervention further complicates treatment decisions. This report describes the case of a 29-year-old man with uncorrected congenital patent ductus arteriosus (PDA) presenting with heart failure and pulmonary artery vegetations removed during PDA surgical ligation. A 29-year-old man with a history of undiagnosed, untreated congenital heart disease presented with worsening symptoms of heart failure. Initial management included diuretic and empirical antibiotic therapy. Echocardiography and cardiac computed tomography revealed a large type C PDA with an 8.9 mm diameter, with multiple mobile vegetations in the pulmonary artery. Inflammatory markers and infection indicators showed significant improvement within 48 hours. On day 3, the patient underwent surgical evacuation of the pulmonary artery vegetations and PDA ligation. The surgery was successful, and vegetation cultures were negative, confirming blood culture-negative infective endocarditis. Given the potential for other difficult-to-culture bacterial infections, antibiotics were continued until 10 days postoperatively. The patient was discharged on day 10 in stable condition. Follow-up echocardiography showed significant improvement with reverse remodelling. This case underscores the importance of aggressive surgical intervention for the removal of pulmonary artery vegetations, irrespective of their size, in reducing the risk of acute pulmonary embolism. The approach was safe, and no significant post-procedure adverse outcomes were noted, offering valuable insights into the management of IE with PDA and pulmonary artery involvement.

1 January 2026 in Journal of Interventional Cardiology
Verified
Journal Article
Open access
CCCharlotte Johanna Cool
Charlotte Johanna Cool
AKAchmad Fitrah Khalid
Achmad Fitrah Khalid
NSNorman Sukmadi
Norman Sukmadi
RPRina Dhyanti Permatasari
Rina Dhyanti Permatasari
Background: Management of sinus venosus atrial septal defect (SVASD), which is usually accompanied by partial anomalous pulmonary venous drainage (PAPVD), remains challenging. While surgical correction effectively addresses both lesions, it may lead to complications such as sinus node dysfunction (SND), residual shunting, and stenosis of the superior vena cava (SVC) or pulmonary veins. Recently, transcatheter closure with covered stents has emerged as an alternative, though evidence regarding procedural details, safety, and long‐term efficacy remains limited. Methods: Following PRISMA guidelines, we performed a systematic review registered in PROSPERO (CRD420251127217). We included English‐language randomized trials, cohort studies, case–control studies, and cross‐sectional reports. Searches were conducted in PubMed, EBSCOHost, ProQuest, and via manual reference screening using terms “Percutaneous Repair” and “Sinus Venosus Atrial Septal Defect.” Results: Out of 295 articles, seven studies involving 403 patients were included. Cross‐sectional imaging with cardiac computed tomography (CT) or magnetic resonance imaging (MRI) was used to guide intervention planning. Techniques varied in venous access and balloon occlusion test. All cases utilized 10‐zig covered stents, occasionally supplemented by anchoring stents. Major complications, including stent embolization and pericardial effusion, were infrequent and resolved without sequelae. In one comparative study, transcatheter repair was associated with shorter hospitalization. Follow‐up demonstrated consistent reductions in the right ventricular size and flow ratio, minimal residual defects, and no late‐onset SND. Conclusion: Transcatheter repair of SVASD appears to be a feasible and safe alternative to surgery, demonstrating encouraging mid‐term outcomes. Further large‐scale comparative trials with longer follow‐up are needed to confirm long‐term efficacy and optimize patient selection.

6 November 2025 in Journal of Asian Pacific Society of Cardiology
Verified
Journal Article
Open access
PDF file
DADyah Wulan Anggrahini
Dyah Wulan Anggrahini
DNDetty Siti Nurdiati
Detty Siti Nurdiati
AHAnggoro Budi Hartopo
Anggoro Budi Hartopo
AHAthanasius Wrin Hudoyo
Athanasius Wrin Hudoyo
PSPrenali Dwisthi Sattwika
Prenali Dwisthi Sattwika
LDLucia Kris Dinarti
Lucia Kris Dinarti
Congenital heart disease (CHD) and pulmonary hypertension represent significant risk factors for adverse pregnancy outcomes and are associated with considerable maternal mortality, contributing to approximately 9% of maternal deaths globally. Among cardiovascular diseases complicating pregnancy, CHD is the most prevalent subtype. Here we conducted a comprehensive literature review on maternal and foetal outcomes associated with adult CHD-related pulmonary hypertension, also incorporating data from four pulmonary hypertension centres in Indonesia. Consistent with global epidemiological trends, atrial septal defect emerged as the most frequently observed form of CHD, followed by ventricular septal defect, across the four Indonesian centres. Maternal cardiovascular complications in this context include heart failure, arrhythmias, pulmonary hypertensive crises, thromboembolic events and aortic dissection. These haemodynamic disturbances further elevate the risk of adverse foetal outcomes, such as prematurity, low birth weight, intrauterine growth restriction and foetal demise. Effective and timely management of CHD and pulmonary hypertension – centred on optimising right ventricular function during pregnancy – is critical. Implementation of a comprehensive, multidisciplinary care approach, alongside the expansion of screening programmes for CHD in pregnant populations, is essential to improve maternal and foetal outcomes.